Gohomeway Group Inc. Completes EU Trademark Registration, Marking a Key Step in Global Branding

LISHUI, China, May 12, 2025 /PRNewswire/ — Tantech Holdings Ltd (NASDAQ: TANH),…

Access a Diversified and Resilient Market Amidst Volatilities–CSOP FTSE Asia Pacific Select REITs ETF (3447.HK) to List on HKEX Tomorrow

HONG KONG, May 12, 2025 /PRNewswire/ — CSOP FTSE Asia Pacific Select…

Astronergy shines with its breakthroughs at Intersolar Europe 2025

No busbars, no limits: Astronergy showcases ZBB-powered solar breakthroughs in Munich MUNICH, May…

Vipshop to Announce First Quarter 2025 Financial Results on May 20, 2025

GUANGZHOU, China, May 12, 2025 /PRNewswire/ — Vipshop Holdings Limited (NYSE: VIPS),…

Arya.ai Unveils MCP Applications to Transform Generic LLMs into Domain-Specific Experts

MUMBAI, India and NEW YORK, May 12, 2025 /PRNewswire/ — Arya.ai today…

HashKey Group Announces Launch of HashKey Global MENA with VASP License in UAE

HONG KONG, May 12, 2025 /PRNewswire/ — HashKey Group ("HashKey"), a leading…

Allianz Partners India – Travel Index 2025

A quarter of Indians planning to travel in 2025 want to travel…

Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic ‌Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS

YANTAI, China, May 12, 2025 /PRNewswire/ — On May 12th, 2025, RemeGen…